Final results of initial Canadian SARS-CoV-2 seroprevalence study announced

Study suggests as few as 0.7% of adults have antibodies to SARS-CoV-2 Canadian Blood Services and Canada’s COVID-19 Immunity Task Force (CITF) are releasing final results of a collaborative nine-province SARS-CoV-2 seroprevalence study. This analysis, based on 37,373 blood samples from blood donor centres across Canada (except Quebec and the Territories), reveals that fewer than 1 per … Continue reading Final results of initial Canadian SARS-CoV-2 seroprevalence study announced